Last updated on October 2018

Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer


Brief description of study

The purpose of study is to compare the efficacy and safety of ONO-4538 in combination with carboplatin, paclitaxel, and bevacizumab (ONO-4538 group) to placebo in combination with carboplatin, paclitaxel, and bevacizumab (placebo group) in chemotherapy-nave subjects with stage IIIB/IV or recurrent non-squamous non-small cell lung cancer unsuitable for radical radiation in a multicenter, randomized, double-blind study.

Clinical Study Identifier: NCT03117049

Contact Investigators or Research Sites near you

Start Over

Saitama Clinical Site

Kitaadachi-gun, Japan
  Connect »

Chungcheongbuk-do Clinical Site

Cheongju-si, Korea, Republic of
  Connect »

Gyeonggi-do Clinical Site

Seongnam-si, Korea, Republic of
  Connect »

Gyeongsangnam-do Clinical Site

Jinju-si, Korea, Republic of
  Connect »

Daegu Clinical Site

Daegu, Korea, Republic of
  Connect »

Busan Clinical Site

Busan, Korea, Republic of
  Connect »

Incheon Clinical Site

Incheon, Korea, Republic of
  Connect »

Seoul Clinical Site2

Seoul, Korea, Republic of
  Connect »

Seoul Clinical Site3

Seoul, Korea, Republic of
  Connect »

Seoul Clinical Site4

Seoul, Korea, Republic of
  Connect »

Seoul Clinical Site5

Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.